Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

ASH: Pfizer eyes re-launch of Mylotarg

Data supports drug's use in acute myeloid leukaemia

Eli Lilly HQ

Lilly reports first pivotal data for Xeljanz rival in arthritis

Baricitinib on course for regulatory filing in late 2015

- PMLiVE

Cancer care celebrated at awards

QiC Oncology programme recognises teams working to improve patient outcomes in oncology

UK flag

Education at heart of new UK diabetes guidelines

NICE recommends new standards for adults with type 1 and children with either type 1 or type 2

- PMLiVE

Mind names YouTube star as first digital ambassador

Zoella launches #DontPanicButton campaign to raise awareness of anxiety

- PMLiVE

Former UK health secretary joins FTI Consulting

Patricia Hewitt to advise on public affairs

- PMLiVE

Creativity in health communications

Does the industry have the courage to push boundaries?

- PMLiVE

ASH: Pradaxa antidote effective in key patient groups

Boehringer posts positive data on use of idarucizumab in elderly and people with kidney impairment

National Institute for Health and Care Excellence NICE logo

Janssen sways NICE with Stelara discount

UK health watchdog set to recommend drug in psoriatic arthritis after agreeing patient access scheme

- PMLiVE

Amgen’s Xgeva cleared in US for rare bone cancer complication

Hypercalcaemia of malignancy affects around 2.7% of cancer patients

- PMLiVE

Thousands more seek lung cancer tests thanks to campaign

Be Clear on Cancer campaign coincided with 3,000 extra GP referrals

- PMLiVE

Pharmacy should move to a ‘wellness-based’ service

There’s a greater preventative role for pharmacists, says RPS

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links